Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Theodore

Showing results (191-200 of 237) with videos related to

Pageof 24
Sort By:
Current Medical Research and Opinion|October 18, 2013
BG-12 (dimethyl fumarate): a review of mechanism of action, efficacy, and safetyRobert J Fox, Mariko Kita, Stanley L Cohan, et al.
International Journal of MS Care|October 17, 2015
Clinical Significance of Gastrointestinal and Flushing Events in Patients with Multiple Sclerosis Treated with Delayed-Release Dimethyl FumarateJ Theodore Phillips, Krzysztof Selmaj, Ralf Gold, et al.
Journal of Neurology|June 11, 2013
Clinical efficacy of BG-12 (dimethyl fumarate) in patients with relapsing-remitting multiple sclerosis: subgroup analyses of the CONFIRM studyMichael Hutchinson, Robert J Fox, David H Miller, et al.
Clinical Therapeutics|March 11, 2018
Corrigendum to 'Effects of Delayed-release Dimethyl Fumarate (DMF) on Health-related Quality of Life in Patients With Relapsing-remitting Multiple Sclerosis: An Integrated Analysis of the Phase 3 DEFINE and CONFIRM Studies: [Clinical Therapeutics 36 (2014) 1958-1971]Mariko Kita, Robert J Fox, Ralf Gold, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 8, 2005
Recent immune status determines the source of antigens that drive homeostatic T cell expansionWilliam C Kieper, Amy Troy, J Theodore Burghardt, et al.
Neurology and Therapy|November 4, 2015
Consensus Management of Gastrointestinal Events Associated with Delayed-Release Dimethyl Fumarate: A Delphi StudyJ Theodore Phillips, April A Erwin, Stephanie Agrella, et al.
Clinical Therapeutics|October 16, 2014
Effects of delayed-release dimethyl fumarate (DMF) on health-related quality of life in patients with relapsing-remitting multiple sclerosis: an integrated analysis of the phase 3 DEFINE and CONFIRM studiesMariko Kita, Robert J Fox, Ralf Gold, et al.
The Journal of Heart Transplantation|July 1, 1985
Late airflow obstruction in heart-lung transplantation recipientsC M Burke, A J Morris, K D Dawkins, et al.
The Annals of Thoracic Surgery|December 1, 1995
Obliterative bronchiolitis after lung and heart-lung transplantationH Reichenspurner, R E Girgis, R C Robbins, et al.
Circulation|May 1, 1985
Long-term results, hemodynamics, and complications after combined heart and lung transplantationK D Dawkins, S W Jamieson, S A Hunt, et al.
Pageof 24

Showing results (191-200 of 237) with videos related to

Sort By:
Pageof 24
Current Medical Research and Opinion|October 18, 2013
BG-12 (dimethyl fumarate): a review of mechanism of action, efficacy, and safetyRobert J Fox, Mariko Kita, Stanley L Cohan, et al.
International Journal of MS Care|October 17, 2015
Clinical Significance of Gastrointestinal and Flushing Events in Patients with Multiple Sclerosis Treated with Delayed-Release Dimethyl FumarateJ Theodore Phillips, Krzysztof Selmaj, Ralf Gold, et al.
Journal of Neurology|June 11, 2013
Clinical efficacy of BG-12 (dimethyl fumarate) in patients with relapsing-remitting multiple sclerosis: subgroup analyses of the CONFIRM studyMichael Hutchinson, Robert J Fox, David H Miller, et al.
Clinical Therapeutics|March 11, 2018
Corrigendum to 'Effects of Delayed-release Dimethyl Fumarate (DMF) on Health-related Quality of Life in Patients With Relapsing-remitting Multiple Sclerosis: An Integrated Analysis of the Phase 3 DEFINE and CONFIRM Studies: [Clinical Therapeutics 36 (2014) 1958-1971]Mariko Kita, Robert J Fox, Ralf Gold, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 8, 2005
Recent immune status determines the source of antigens that drive homeostatic T cell expansionWilliam C Kieper, Amy Troy, J Theodore Burghardt, et al.
Neurology and Therapy|November 4, 2015
Consensus Management of Gastrointestinal Events Associated with Delayed-Release Dimethyl Fumarate: A Delphi StudyJ Theodore Phillips, April A Erwin, Stephanie Agrella, et al.
Clinical Therapeutics|October 16, 2014
Effects of delayed-release dimethyl fumarate (DMF) on health-related quality of life in patients with relapsing-remitting multiple sclerosis: an integrated analysis of the phase 3 DEFINE and CONFIRM studiesMariko Kita, Robert J Fox, Ralf Gold, et al.
The Journal of Heart Transplantation|July 1, 1985
Late airflow obstruction in heart-lung transplantation recipientsC M Burke, A J Morris, K D Dawkins, et al.
The Annals of Thoracic Surgery|December 1, 1995
Obliterative bronchiolitis after lung and heart-lung transplantationH Reichenspurner, R E Girgis, R C Robbins, et al.
Circulation|May 1, 1985
Long-term results, hemodynamics, and complications after combined heart and lung transplantationK D Dawkins, S W Jamieson, S A Hunt, et al.
Pageof 24